Title: Head-to-head prenyl tranferases: anti-infective drug targets.
Journal: Journal of medicinal chemistry 20120510
Title: SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro.
Journal: The Journal of antimicrobial chemotherapy 20120501
Title: Tuberculosis: the drug development pipeline at a glance.
Journal: European journal of medicinal chemistry 20120501
Title: Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
Journal: European journal of medicinal chemistry 20120201
Title: Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Journal: PloS one 20120101
Title: Design, synthesis, and biological evaluation of novel fluorinated ethanolamines.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany) 20111223
Title: Novel linear diamine disubstituted polycyclic 'cage' derivatives as potential antimycobacterial candidates.
Journal: Chemical biology & drug design 20111201
Title: The many faces of the adamantyl group in drug design.
Journal: European journal of medicinal chemistry 20110601
Title: [Present and future in the use of anti-tubercular drugs].
Journal: Pneumologia (Bucharest, Romania) 20110101
Title: Drugs in development for tuberculosis.
Journal: Drugs 20101203
Title: In vitro interactions between new antitubercular drug candidates SQ109 and TMC207.
Journal: Antimicrobial agents and chemotherapy 20100701
Title: Current development and future prospects in chemotherapy of tuberculosis.
Journal: Respirology (Carlton, Vic.) 20100701
Title: Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
Journal: European journal of medicinal chemistry 20100501
Title: Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents.
Journal: European journal of medicinal chemistry 20091101
Title: Synthesis and evaluation of carbamate prodrugs of SQ109 as antituberculosis agents.
Journal: Bioorganic & medicinal chemistry letters 20090515
Title: SQ109.
Journal: Tuberculosis (Edinburgh, Scotland) 20080301
Title: New anti-tuberculosis drugs with novel mechanisms of action.
Journal: Current medicinal chemistry 20080101
Title: Advances in the treatment of tuberculosis.
Journal: Clinical pharmacology and therapeutics 20071101
Title: New tuberculosis therapeutics: a growing pipeline.
Journal: The Journal of infectious diseases 20070815
Title: Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs.
Journal: Antimicrobial agents and chemotherapy 20070401
Title: Novel agents in the management of Mycobacterium tuberculosis disease.
Journal: Current medicinal chemistry 20070101
Title: Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.
Journal: The Journal of antimicrobial chemotherapy 20060801
Title: Interspecies pharmacokinetics and in vitro metabolism of SQ109.
Journal: British journal of pharmacology 20060301
Title: Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37Rv.
Journal: The Journal of pharmacology and experimental therapeutics 20051101
Title: Veiga-Santos P, et al. SQ109, a new drug lead for Chagas disease. Antimicrob Agents Chemother. 2015 Apr;59(4):1950-61.
Title: Jia L, et al. Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug. Br J Pharmacol. 2005 Jan;144(1):80-7
Title: Jia L, et al. Interspecies pharmacokinetics and in vitro metabolism of SQ109. Br J Pharmacol. 2006 Mar;147(5):476-85.
